// STATE LEGISLATION TRACKER

Minnesota SF 2782: Omnibus Labor and Industry appropriations

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Minnesota
Bill: SF 2782
Filed: 2023-03-09
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Minnesota SF2782 is a labor and industry budget/policy bill, not a health care or drug-access bill. It does not appear to change compounded peptide access, off-label prescribing, telehealth prescribing, naturopathic or NP scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No apparent changes to compounded peptide prescribing or dispensing
No telehealth prescribing rules appear to be created or narrowed
No NP or naturopath scope-of-practice changes are indicated
No FDA 503A or 503B compounding provisions are apparent
Combative sports drug-testing language is narrow and not a peptide-access rule

What to Watch For

Note This is mainly a labor and industry bill, so peptide users should not expect access changes from it.

Note Combative sports provisions may matter only to licensed fighters subject to state-regulated drug testing.

Note If language was later folded into SF3035, review that enacted bill for any final changes.

Where the Bill Stands

SF2782 was laid over in Senate Finance on April 12, 2023 for possible inclusion in SF3035 and did not pass as a standalone bill before the 2023-2024 session ended.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws